IFNA1 and type 1 diabetes mellitus: In our opinion, screening for islet antibodies should be considered in patients with increased risk for T1D, such as patients with first degree relatives with T1D, patients with known autoimmune conditions, and HCV patients receiving IFNα (Figure 4).